"Venkys: Double Bottom Breakout Potential with Rising Institutional Confidence"
Stock: Venkys India Ltd.
Analysis:
Venkys appears to be reversing its downtrend and is on the verge of a double bottom breakout, signaling a potential uptrend in the near term. Despite recent weak financial results leading to a sharp correction, growing institutional interest and evolving market opportunities make this stock worth watching.
Key Highlights:
Technical Setup:
Double Bottom Breakout: The stock is nearing a critical breakout level, supported by increased volumes.
CMP: ₹1,848.
Institutional Activity:
FII/FPI Holdings: Increased from 1.40% to 1.88% in Sep 2024 quarter.
FII/FPI Investors: Rose from 48 to 59 in Sep 2024 quarter.
Mutual Funds: Increased holdings from 0.06% to 0.08%.
Total Institutional Holdings: Grew from 1.61% to 2.11%.
Opportunities:
Rising consumer awareness about health and nutrition is driving demand for protein-rich diets, including poultry products.
Export potential in emerging markets and countries with low domestic poultry production.
Threats:
Intense competition from domestic and global players.
Vulnerability to avian diseases such as bird flu, which can impact operations and consumer confidence.
Trade Plan:
CMP: ₹1,848.
Targets:
Near-term: ₹2,138.
Extended: ₹2,436.
Stop Loss: ₹1,650 for swing trades.
Disclaimer:
This analysis is for educational purposes only and is not financial advice. Please perform your own research or consult a financial advisor before making investment decisions.
Stock: Venkys India Ltd.
Analysis:
Venkys appears to be reversing its downtrend and is on the verge of a double bottom breakout, signaling a potential uptrend in the near term. Despite recent weak financial results leading to a sharp correction, growing institutional interest and evolving market opportunities make this stock worth watching.
Key Highlights:
Technical Setup:
Double Bottom Breakout: The stock is nearing a critical breakout level, supported by increased volumes.
CMP: ₹1,848.
Institutional Activity:
FII/FPI Holdings: Increased from 1.40% to 1.88% in Sep 2024 quarter.
FII/FPI Investors: Rose from 48 to 59 in Sep 2024 quarter.
Mutual Funds: Increased holdings from 0.06% to 0.08%.
Total Institutional Holdings: Grew from 1.61% to 2.11%.
Opportunities:
Rising consumer awareness about health and nutrition is driving demand for protein-rich diets, including poultry products.
Export potential in emerging markets and countries with low domestic poultry production.
Threats:
Intense competition from domestic and global players.
Vulnerability to avian diseases such as bird flu, which can impact operations and consumer confidence.
Trade Plan:
CMP: ₹1,848.
Targets:
Near-term: ₹2,138.
Extended: ₹2,436.
Stop Loss: ₹1,650 for swing trades.
Disclaimer:
This analysis is for educational purposes only and is not financial advice. Please perform your own research or consult a financial advisor before making investment decisions.
Learn, Profit & Share
Join FREE Telegram channel: t.me/learnprofitshare
Ask Question on Twitter I research and reply: x.com/LearnPShare
Subscribe Youtube channel 4 FREE learning:
youtube.com/@learnprofitshare
Join FREE Telegram channel: t.me/learnprofitshare
Ask Question on Twitter I research and reply: x.com/LearnPShare
Subscribe Youtube channel 4 FREE learning:
youtube.com/@learnprofitshare
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Learn, Profit & Share
Join FREE Telegram channel: t.me/learnprofitshare
Ask Question on Twitter I research and reply: x.com/LearnPShare
Subscribe Youtube channel 4 FREE learning:
youtube.com/@learnprofitshare
Join FREE Telegram channel: t.me/learnprofitshare
Ask Question on Twitter I research and reply: x.com/LearnPShare
Subscribe Youtube channel 4 FREE learning:
youtube.com/@learnprofitshare
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.